BG
BNTX icon

Bellevue Group’s BioNTech BNTX Stock Holding History

Bellevue Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
21,229
+378
+2% +$35.6K 0.04% 94
2026
Q1 		$1.85M Sell
20,851
-22,904
-52% -$2.35M 0.04% 80
2025
Q4 		$4.17M Buy
43,755
+9,800
+29% +$987K 0.08% 79
2025
Q3 		$3.35M Sell
33,955
-1,084
-3% -$116K 0.07% 85
2025
Q2 		$3.73M Buy
35,039
+27,075
+340% +$2.73M 0.08% 87
2025
Q1 		$725K Sell
7,964
-368
-4% -$41.2K 0.02% 113
2024
Q4 		$949K Sell
8,332
-389
-4% -$44.4K 0.02% 118
2024
Q3 		$1.04M Buy
+8,721
New +$802K 0.02% 116
2023
Q2 		– Sell
-196,480
Closed -$24.5M – 158
2023
Q1 		$24.5M Sell
196,480
-24,600
-11% -$3.38M 0.36% 70
2022
Q4 		$33.2M Buy
221,080
+67,500
+44% +$10.4M 0.44% 65
2022
Q3 		$20.7M Buy
153,580
+2,380
+2% +$364K 0.3% 82
2022
Q2 		$22.5M Buy
151,200
+39,434
+35% +$6.03M 0.32% 81
2022
Q1 		$19.1M Sell
111,766
-1,700
-1% -$286K 0.22% 95
2021
Q4 		$29.3M Buy
113,466
+100,766
+793% +$27.6M 0.3% 89
2021
Q3 		$3.47M Sell
12,700
-9,900
-44% -$3.15M 0.04% 137
2021
Q2 		$5.06M Sell
22,600
-22,900
-50% -$4.32M 0.05% 132
2021
Q1 		$4.97M Buy
45,500
+27,500
+153% +$2.92M 0.05% 130
2020
Q4 		$1.47M Sell
18,000
-31,500
-64% -$3.09M 0.02% 150
2020
Q3 		$3.43M Sell
49,500
-500
-1% -$35.9K 0.05% 132
2020
Q2 		$3.34M Buy
+50,000
New +$2.5M 0.05% 127

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Bellevue Group's BNTX Position: Q2 2026 in Review

Bellevue Group increased its BioNTech (BNTX) stake by 1.8% in Q2 2026, buying an estimated $35.6K and bringing the position to 21,229 shares worth $1.98M. The position accounts for 0.04% of the portfolio, ranked #94.

Bellevue Group first reported a position in BNTX in Q2 2020 and has held it in 20 quarters since. The position peaked at $33.2M in Q4 2022. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Bellevue Group held 21,229 shares of BioNTech worth $1.98M as of Q2 2026.
  • Bellevue Group bought 378 BioNTech shares in Q2 2026, an estimated $35.6K.
  • BioNTech made up 0.04% of Bellevue Group's portfolio in Q2 2026, its #94 holding.
  • Bellevue Group first reported a position in BioNTech in Q2 2020 and has held it in 20 quarters since.
  • Bellevue Group's BioNTech position peaked at $33.2M in Q4 2022.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.